Source: http://health.yahoo.net/news/s/nm/astex-pharma-to-discontinue-development-of-lung-cancer-drug
Sunday, 23 September 2012
Astex Pharma to discontinue development of lung cancer drug
(Reuters) - Astex Pharmaceuticals Inc said it would discontinue the development of its experimental small-cell lung cancer drug amuvatinib as the drug failed to meet the main goal of a mid-stage study. The main goal of the study was to show that t...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.